Full-Life Technologies Appoints Edward Myles To Board Of Directors
21 Jul 2024 //
PR NEWSWIRE
SK Signs $572M Deal With Full-Life For Radiopharma Leadership
17 Jul 2024 //
FIERCE BIOTECH
Full-Life And SK Biopharm License Novel Solid Tumor Therapy
17 Jul 2024 //
PR NEWSWIRE
US FDA grants fast track designation to Full-Life Technologies to treat Cancer
04 Jul 2024 //
PHARMABIZ
Full-Life`s 225Ac-FL-020 Gets FDA Fast Track For Prostate Cancer Treatment
02 Jul 2024 //
PR NEWSWIRE
Full-Life FDA Clears 225Ac-FL-020 IND For Metastatic CRPC
29 May 2024 //
PR NEWSWIRE
Full-Life Technologies Appoints Mark de Jong As CTO
16 May 2024 //
PR NEWSWIRE
Full-Life Technologies Appoints CMO and CSO
17 Jan 2023 //
CONTRACT PHARMA
Full-Life Announces Appointment of Steffen Heeger as CMO and Fa Liu as CSO
16 Jan 2023 //
PR NEWSWIRE
Full-Life acquires Focus-X in $245M biobucks deal
29 Nov 2022 //
FIERCEBIOTECH